ERBB2 and breast cancer: Previous studies reported an association between APOBEC3B expression and aggressive characteristics of the primary breast cancer, including high histologic grade, genomic grade, advanced stage, negative ERα status and HER2/ERBB2 amplification [21,23,28,29,35].